9/8/2006

The FDA approved Watson Pharmaceuticals' generic version of Barr Pharmaceuticals' Seasonale extended-cycle oral contraceptive. Barr responded by saying it would launch its own generic version of Seasonale, which had sales of $110 million over the past year.

Related Summaries